Traduction de «therapeutic products fees ordinance » (Anglais → Français) :

The key deliverables of the initiative include an assessment of the TPP cost-recovery initiative as it relates to the Treasury Board cost-recovery policy, and the public and private benefits that have derived from it; a thorough assessment of the current cost-recovery initiative costing model used by the TPP, including a comparison of other regulatory regimes and justifications, identification of any gaps in the current cost-recovery initiative, and the contribution of fees to the delivery of an efficient service; an evaluation of whether the cost-recovery initiative has had an impact on the TPP's performance, taking into consideration ...[+++] previous performance commitments, other jurisdictions' experience, options for improving feedback and/or communication mechanisms for stakeholders to foster transparency and accountability, and constraints that might limit my program's ability to manage the cost-recovery initiative and thereby the efficient operations of its programs; an assessment of the direct, indirect, and cumulative impacts of the cost-recovery initiative on therapeutic products industries, on consumers and the health care system, and on the TPP itself, and the development of a rigorous methodology and relevant data sources for a follow-up assessment of the impact of planned fees on the medical devices regulation area; and finally, a systematic review of lessons learned from other jurisdictions and options for operational and/or organizational alternatives and/or modifications to improve the management of the TPP cost recovery initiative.

The Council adopted the solutions prepared by the Permanent Representatives Committee and the Special Committee on Agriculture on certain points raised at the meeting on 26 February 1996, namely: - the therapeutic use of beta-agonists for cows when calving: this will be allowed provided that it is administered by a veterinarian in the form of an injection, while the holding by the farmer of beta-agonist substances which can be used to treat tocolysis in cows will be prohibited; - the question of reviewing the "prohibition" proposal: a Commission statement will be entered in the Council minutes whereby the Commission unde ...[+++]rtakes to keep under review all developments in relation to the scientific and other aspects of the use of substances in beef and veal production, and to report to the Council on any necessary amendments to the Directives adopted; - the financing of reinforced monitoring measures, particularly on the farm: the Council, acting on a proposal from the Commission, undertakes to amend Directive 85/73/EEC in order to provide for the charging of a fee to cover monitoring carried out pursuant to the Directive.